My research interests include cancer molecular biology, with emphasis on oncogenic signaling networks, cancer stem cell biology, and cancer biomarkers. I am also engaged in studying oxidative DNA damage and repair, focusing on quantitative assessment of oxidative lesions in genomic DNA as biomarkers relevant to cancer development and therapeutic response. In addition, my work incorporates biosensors, microfluidics, and organ-on-a-chip technologies to create quantitative, translational platforms that enable cancer detection and disease modeling.